We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$18.2B
AUM Growth
-$235M
Cap. Flow
-$283M
Cap. Flow %
-1.55%
Top 10 Hldgs %
32.02%
Holding
333
New
17
Increased
37
Reduced
36
Closed
22

Top Buys

Rank Stock Value
1
ZEN
ZENDESK INC
ZEN
+$262M
2
CLVT icon
Clarivate
CLVT
+$202M
3
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$196M
4
SPGI icon
S&P Global
SPGI
+$139M
5
HUM icon
Humana
HUM
+$122M

Top Sells

Rank Stock Value
1
COHR
Coherent Inc
COHR
+$154M
2
HWM icon
Howmet Aerospace
HWM
+$140M
3
CSGP icon
CoStar Group
CSGP
+$139M
4
BSX icon
Boston Scientific
BSX
+$116M
5
MANT
Mantech International Corp
MANT
+$92.7M

Sector Composition

Rank Sector Weight
1 Healthcare 28.16%
2 Technology 19.07%
3 Financials 13.73%
4 Industrials 8.28%
5 Communication Services 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRPT icon
51
Sarepta Therapeutics
SRPT
$1.77B
$83.5M 0.46%
754,950
-430,101
-36% -$43.4M
BIIB icon
52
Biogen
BIIB
$30.7B
$81.6M 0.45%
305,499
+27,000
+10% +$5.73M
MASI
53
DELISTED
Masimo
MASI
$81.4M 0.45%
577,000
+382,000
+196% +$55.8M
ENTA icon
54
Enanta Pharmaceuticals
ENTA
$400M
$80.4M 0.44%
1,550,000
– –
PCG icon
55
PG&E
PCG
$38.5B
$78.8M 0.43%
6,305,142
– –
CYTK icon
56
Cytokinetics
CYTK
$10.4B
$78.5M 0.43%
1,621,038
-624,000
-28% -$30M
AVTR icon
57
Avantor
AVTR
$9.19B
$72.1M 0.4%
3,679,464
-1,600,000
-30% -$42.9M
JAZZ icon
58
Jazz Pharmaceuticals
JAZZ
$16.7B
$71.6M 0.39%
537,500
-382,600
-42% -$58.2M
NLSN
59
DELISTED
Nielsen Holdings plc
NLSN
$68.5M 0.38%
+2,470,976
New +$64.4M
SIMO icon
60
Silicon Motion
SIMO
$8.68B
$60.7M 0.33%
931,510
+155,000
+20% +$12.1M
LU icon
61
Lufax Holding
LU
$1.3B
$52.2M 0.29%
5,134,100
-801,000
-13% -$13.7M
ONEM
62
DELISTED
1Life Healthcare
ONEM
$50.2M 0.28%
+2,925,000
New +$45.9M
BRKR icon
63
Bruker
BRKR
$8.14B
$50.1M 0.28%
943,800
-463,000
-33% -$27.7M
RVMD icon
64
Revolution Medicines
RVMD
$44B
$49.3M 0.27%
2,500,000
-750,000
-23% -$16.5M
TSEM icon
65
Tower Semiconductor
TSEM
$28.5B
$44.6M 0.25%
1,015,000
+65,000
+7% +$2.99M
LH icon
66
Labcorp
LH
$25.9B
$44.1M 0.24%
250,625
-353,158
-58% -$72.3M
AGIO icon
67
Agios Pharmaceuticals
AGIO
$1.93B
$42.3M 0.23%
1,496,829
+163,817
+12% +$4.39M
CCXI
68
DELISTED
ChemoCentryx, Inc.
CCXI
$41.3M 0.23%
+800,000
New +$33.1M
IMGO
69
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$37.2M 0.2%
2,471,313
– –
BABA icon
70
Alibaba
BABA
$308B
$37.1M 0.2%
+464,000
New +$44.2M
CTLT
71
DELISTED
CATALENT, INC.
CTLT
$33.7M 0.19%
465,755
+46,000
+11% +$4.57M
APLS
72
DELISTED
Apellis Pharmaceuticals
APLS
$32.6M 0.18%
+478,000
New +$28.3M
FHN icon
73
First Horizon
FHN
$12.1B
$32.1M 0.18%
+1,400,000
New +$31.8M
IS
74
DELISTED
ironSource Ltd.
IS
$31.4M 0.17%
+9,130,000
New +$34.8M
PTGX icon
75
Protagonist Therapeutics
PTGX
$9.44B
$30.8M 0.17%
3,651,887
-48,721
-1% -$461K
1 2
3
4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Farallon Capital Management held 333 positions worth $18.2B, down 1.3% from $18.4B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Farallon Capital Management's Q3 2022 filing shows 17 new, 37 increased, 36 reduced and 22 closed positions. Its largest new stake was Humana: 251,200 shares worth $122M. The largest sale was Coherent Inc, an estimated $154M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q3 2022 buy was Humana: 251,200 shares worth $122M.
  • Farallon Capital Management added most to ZENDESK INC in Q3 2022, an estimated $262M increase.
  • Farallon Capital Management's biggest Q3 2022 reduction was Howmet Aerospace, cutting an estimated $140M.
  • Farallon Capital Management fully exited Coherent Inc in Q3 2022, selling an estimated $154M.
  • Farallon Capital Management's ten largest holdings make up 32% of its $18.2B portfolio in Q3 2022.
  • Farallon Capital Management opened 17 new positions and closed 22 in Q3 2022.
  • Farallon Capital Management's portfolio value fell 1.3% quarter-over-quarter to $18.2B.

Based on Farallon Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.